Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.

@article{Barad2016CorrelationBT,
  title={Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.},
  author={Voichita Bar-ad and Qiang Zhang and Paul M. Harari and Rita Susan Axelrod and David I. Rosenthal and Andy M. Trotti and Christopher Uwe Jones and Adam Seth Garden and Guobin Song and Robert L. Foote and David Raben and George Shenouda and Sharon A. Spencer and Jonathan Harris and Quynh L{\^e}},
  journal={International journal of radiation oncology, biology, physics},
  year={2016},
  volume={95 5},
  pages={1346-1354}
}
PURPOSE To evaluate the severity of cetuximab-induced skin rash and its correlation with clinical outcome and late skin toxicity in patients with head and neck squamous cell carcinoma treated with chemoradiation therapy and cetuximab. METHODS AND MATERIALS Analysis included patients who received loading dose and ≥1 cetuximab dose concurrent with definitive chemoradiation therapy (70 Gy + cisplatin) or postoperative chemoradiation therapy (60-66 Gy + docetaxel or cisplatin). RESULTS Six… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…